{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:56:26Z","timestamp":1792443386599,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017520","name":"Chengdu Medical College","doi-asserted-by":"publisher","award":["23LHZY04"],"award-info":[{"award-number":["23LHZY04"]}],"id":[{"id":"10.13039\/100017520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2022JDJQ0050"],"award-info":[{"award-number":["2022JDJQ0050"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.apsb.2025.02.035","type":"journal-article","created":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T11:39:07Z","timestamp":1740829147000},"page":"2884-2899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Nose-to-brain delivery of targeted lipid nanoparticles as two-pronged \u03b2-amyloid nanoscavenger for Alzheimer's disease therapy"],"prefix":"10.1016","volume":"15","author":[{"given":"Yanyan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangtong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfeng","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongke","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5355-7238","authenticated-orcid":false,"given":"Huile","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2025.02.035_bib1","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","author":"Nichols","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.apsb.2025.02.035_bib2","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2025.02.035_bib3","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/alz.12638","article-title":"2022 Alzheimer's disease facts and figures","volume":"18","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.apsb.2025.02.035_bib4","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer disease: an update on pathobiology and treatment strategies","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2025.02.035_bib5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13195-016-0207-9","article-title":"Drug development in Alzheimer's disease: the path to 2025","volume":"8","author":"Cummings","year":"2016","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.apsb.2025.02.035_bib6","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","article-title":"The amyloid hypothesis in Alzheimer's disease: new insights from new therapeutics","volume":"21","author":"Karran","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2025.02.035_bib7","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.apsb.2025.02.035_bib8","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1002\/brx2.27","article-title":"Nanomedicines for Alzheimer's disease: therapies based on pathological mechanisms","volume":"1","author":"Cheng","year":"2023","journal-title":"Brain-X"},{"key":"10.1016\/j.apsb.2025.02.035_bib9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S1474-4422(22)00529-4","article-title":"Lecanemab slows Alzheimer's disease: hope and challenges","volume":"22","author":"Mead","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.apsb.2025.02.035_bib10","article-title":"Lecanemab for Alzheimer's disease","volume":"379","author":"Sebastian","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.apsb.2025.02.035_bib11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41570-017-0063","article-title":"Evolution of macromolecular complexity in drug delivery systems","volume":"1","author":"Kakkar","year":"2017","journal-title":"Nat Rev Chem"},{"key":"10.1016\/j.apsb.2025.02.035_bib12","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1212\/WNL.0000000000207505","article-title":"Lecanemab","volume":"101","author":"Burke","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.apsb.2025.02.035_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101339","article-title":"Effects of monoclonal antibodies against amyloid-\u03b2 on clinical and biomarker outcomes and adverse event risks: a systematic review and meta-analysis of phase III RCTs in Alzheimer's disease","volume":"68","author":"Avgerinos","year":"2021","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.apsb.2025.02.035_bib14","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41565-021-00898-0","article-title":"The current landscape of nucleic acid therapeutics","volume":"16","author":"Kulkarni","year":"2021","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2025.02.035_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2025.02.035_bib16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/d41586-018-05867-7","article-title":"Gene-silencing technology gets first drug approval after 20-year wait","volume":"560","author":"Ledford","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.02.035_bib17","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nn1531","article-title":"Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model","volume":"8","author":"Singer","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.apsb.2025.02.035_bib18","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jconrel.2018.04.034","article-title":"Systemic delivery of BACE1 siRNA through neuron-targeted nanocomplexes for treatment of Alzheimer's disease","volume":"279","author":"Wang","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.02.035_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202203182","article-title":"Intranasal delivery of BACE1 siRNA and rapamycin by dual targets modified nanoparticles for Alzheimer's disease therapy","volume":"18","author":"Yang","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.apsb.2025.02.035_bib20","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1002\/brx2.68","article-title":"Advances of therapy for Alzheimer's disease: an updated review","volume":"2","author":"Mei","year":"2024","journal-title":"Brain X"},{"key":"10.1016\/j.apsb.2025.02.035_bib21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41582-024-00940-4","article-title":"Is Alzheimer disease a disease?.","volume":"20","author":"Korczyn","year":"2024","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.apsb.2025.02.035_bib22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer's disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2025.02.035_bib23","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.apsb.2022.07.014","article-title":"Nanopolyphenol rejuvenates microglial surveillance of multiple misfolded proteins through metabolic reprogramming","volume":"13","author":"Wang","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.02.035_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2016.01.055","article-title":"Nanoformulated alpha-mangostin ameliorates Alzheimer's disease neuropathology by elevating LDLR expression and accelerating amyloid-beta clearance","volume":"226","author":"Yao","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.02.035_bib25","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/s41578-021-00379-9","article-title":"From lipids to lipid nanoparticles to mRNA vaccines","volume":"6","author":"Horejs","year":"2021","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.apsb.2025.02.035_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202203669","article-title":"Lipid nanoparticle technologies for nucleic acid delivery: a nanoarchitectonics perspective","volume":"32","author":"Ferhan","year":"2022","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.apsb.2025.02.035_bib27","article-title":"Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment","volume":"34","author":"Liu","year":"2023","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.apsb.2025.02.035_bib28","article-title":"Elaborately engineering of lipid nanoparticle for targeting delivery of siRNA and suppressing acute liver injury","volume":"35","author":"Wang","year":"2024","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.apsb.2025.02.035_bib29","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1021\/acs.bioconjchem.0c00366","article-title":"The biomolecular corona of lipid nanoparticles for gene therapy","volume":"31","author":"Francia","year":"2020","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.apsb.2025.02.035_bib30","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1021\/acs.molpharmaceut.2c00442","article-title":"Lipid nanoparticle (LNP) chemistry can endow unique in vivo RNA delivery fates within the liver that alter therapeutic outcomes in a cancer model","volume":"19","author":"Johnson","year":"2022","journal-title":"Mol Pharmaceutics"},{"key":"10.1016\/j.apsb.2025.02.035_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201805308","article-title":"Dendrimer-based lipid nanoparticles deliver therapeutic FAH mRNA to normalize liver function and extend survival in a mouse model of hepatorenal tyrosinemia type I","volume":"30","author":"Cheng","year":"2018","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2025.02.035_bib32","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1080\/17425247.2023.2245332","article-title":"Influence factors on and potential strategies to amplify receptor-mediated nanodrug delivery across the blood\u2013brain barrier","volume":"20","author":"Wei","year":"2023","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.apsb.2025.02.035_bib33","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jconrel.2021.06.007","article-title":"Usefulness of cell-penetrating peptides and penetration accelerating sequence for nose-to-brain delivery of glucagon-like peptide-2","volume":"335","author":"Akita","year":"2021","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.02.035_bib34","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jconrel.2023.06.005","article-title":"Effective nose-to-brain drug delivery using a combination system targeting the olfactory region in monkeys","volume":"359","author":"Sasaki","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.02.035_bib35","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jconrel.2023.12.054","article-title":"Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases","volume":"366","author":"Huang","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.02.035_bib36","first-page":"19","article-title":"Immune cells: potential carriers or agents for drug delivery to the central nervous system","volume":"11","author":"Zhang","year":"2024","journal-title":"Mil Med Res"},{"key":"10.1016\/j.apsb.2025.02.035_bib37","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jconrel.2021.12.009","article-title":"Convolutions in the rendition of nose to brain therapeutics from bench to bedside: feats & fallacies","volume":"341","author":"Goel","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.02.035_bib38","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1016\/j.biomaterials.2013.08.036","article-title":"Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles","volume":"34","author":"Kanazawa","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2025.02.035_bib39","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/cne.10143","article-title":"Trigeminal collaterals in the nasal epithelium and olfactory bulb: a potential route for direct modulation of olfactory information by trigeminal stimuli","volume":"444","author":"Schaefer","year":"2002","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.apsb.2025.02.035_bib40","article-title":"Engineering of structural and functional properties of nanotherapeutics and nanodiagnostics for intranasal brain targeting in Alzheimer's","volume":"26","author":"Hinge","year":"2022","journal-title":"Appl Mater Today"},{"key":"10.1016\/j.apsb.2025.02.035_bib41","article-title":"Nose-to-brain drug delivery: challenges and progress towards brain targeting in the treatment of neurological disorders","volume":"86","author":"Raghav","year":"2023","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.apsb.2025.02.035_bib42","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41467-022-35637-z","article-title":"Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis","volume":"14","author":"Han","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.02.035_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120355","article-title":"Lactoferrin, a multi-functional glycoprotein: active therapeutic, drug nanocarrier & targeting ligand","volume":"263","author":"Elzoghby","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2025.02.035_bib44","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijpharm.2011.05.062","article-title":"Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: preparation, characterization and efficacy in Parkinson's disease","volume":"415","author":"Hu","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2025.02.035_bib45","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1016\/j.biomaterials.2013.02.003","article-title":"Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration","volume":"34","author":"Liu","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2025.02.035_bib46","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1080\/10717544.2019.1636420","article-title":"Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson's disease","volume":"26","author":"Tang","year":"2019","journal-title":"Drug Deliv"},{"key":"10.1016\/j.apsb.2025.02.035_bib47","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1002\/jcp.22650","article-title":"Apo- and holo-lactoferrin are both internalized by lactoferrin receptor via clathrin-mediated endocytosis but differentially affect ERK-signaling and cell proliferation in caco-2 cells","volume":"226","author":"Jiang","year":"2011","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.apsb.2025.02.035_bib48","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.1016\/j.apsb.2024.05.017","article-title":"Counteracting Alzheimer's disease via normalizing neurovascular unit with a self-regulated multi-functional nano-modulator","volume":"14","author":"Xia","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.02.035_bib49","doi-asserted-by":"crossref","first-page":"6621","DOI":"10.1038\/s41598-021-86037-0","article-title":"Long-term evolution of the epithelial cell secretome in preclinical 3D models of the human bronchial epithelium","volume":"11","author":"Sanchez-Guzman","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2025.02.035_bib50","doi-asserted-by":"crossref","first-page":"180","DOI":"10.34133\/research.0180","article-title":"Pathological BBB crossing melanin-like nanoparticles as metal-ion chelators and neuroinflammation regulators against Alzheimer's disease","volume":"6","author":"Huang","year":"2023","journal-title":"Research"},{"key":"10.1016\/j.apsb.2025.02.035_bib51","article-title":"lysosome-targeting protein degradation through endocytosis pathway triggered by polyvalent nano-chimera for AD therapy","volume":"37","author":"Wang","year":"2024","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2025.02.035_bib52","doi-asserted-by":"crossref","first-page":"29779","DOI":"10.1021\/acsnano.4c09449","article-title":"Intranasal carrier-free nanomodulator addresses both symptomatology and etiology of Alzheimer's disease by restoring neuron plasticity and reprogramming lesion microenvironment","volume":"18","author":"Yang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2025.02.035_bib53","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1021\/acsnano.3c09715","article-title":"Mannose-integrated nanoparticle hitchhike glucose transporter 1 recycling to overcome various barriers of oral delivery for Alzheimer's disease therapy","volume":"18","author":"Lei","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2025.02.035_bib54","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41593-020-0624-8","article-title":"Disease-associated astrocytes in Alzheimer's disease and aging","volume":"23","author":"Habib","year":"2020","journal-title":"Nat Neurosci"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525001182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525001182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:20:10Z","timestamp":1762604410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383525001182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2211383525001182"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2025.02.035","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nose-to-brain delivery of targeted lipid nanoparticles as two-pronged \u03b2-amyloid nanoscavenger for Alzheimer's disease therapy","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2025.02.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}